Moneycontrol
Last Updated : Jan 11, 2019 06:09 PM IST | Source: Moneycontrol.com

Sun Pharma Q3 PAT seen up 178.4% YoY to Rs. 1,017.1 cr: ICICI Direct

Net Sales are expected to increase by 14.4 percent Y-o-Y (up 9.7 percent Q-o-Q) to Rs. 7,609 crore, according to ICICI Direct.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct has come out with its third quarter (October-December’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Sun Pharma to report net profit at Rs. 1,017.1 crore up 178.4% year-on-year (up 2.2% quarter-on-quarter).


Net Sales are expected to increase by 14.4 percent Y-o-Y (up 9.7 percent Q-o-Q) to Rs. 7,609 crore, according to ICICI Direct.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 17.8 percent Y-o-Y (up 11.8 percent Q-o-Q) to Rs. 1,712 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Jan 11, 2019 06:09 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant